Amedeo Smart

Free Medical Literature Service



Ovarian Neoplasms

  Free Subscription


1 Am J Obstet Gynecol
1 Ann Oncol
3 BMC Cancer
2 Br J Cancer
1 Int J Cancer
1 J Clin Oncol
2 Lancet Oncol

    Am J Obstet Gynecol

  1. MORUZZI MC, Bolomini G, Esposito R, Mascilini F, et al
    Diagnostic performance of ultrasound in assessing the extension of disease in advanced ovarian cancer.
    Am J Obstet Gynecol. 2022 Jun 22. pii: S0002-9378(22)00367.
    >> Share

    Ann Oncol

  2. FRENEL JS, Kim JW, Aryal N, Asher R, et al
    Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial.
    Ann Oncol. 2022 Jun 27. pii: S0923-7534(22)01740.
    >> Share

    BMC Cancer

  3. SOHN EJ
    PIK3R3, a regulatory subunit of PI3K, modulates ovarian cancer stem cells and ovarian cancer development and progression by integrative analysis.
    BMC Cancer. 2022;22:708.
    >> Share

  4. LIM H, Bang SH, Kim Y, Cho SH, et al
    Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study.
    BMC Cancer. 2022;22:703.
    >> Share

  5. BORDE J, Laitman Y, Blumcke B, Niederacher D, et al
    Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers.
    BMC Cancer. 2022;22:706.
    >> Share

    Br J Cancer

  6. SASAMOTO N, Wang T, Townsend MK, Eliassen AH, et al
    Pre-diagnosis and post-diagnosis dietary patterns and survival in women with ovarian cancer.
    Br J Cancer. 2022 Jun 27. pii: 10.1038/s41416-022-01901.
    >> Share

  7. KAMAT K, Krishnan V, Dorigo O
    Macrophage-derived CCL23 upregulates expression of T-cell exhaustion markers in ovarian cancer.
    Br J Cancer. 2022 Jun 24. pii: 10.1038/s41416-022-01887.
    >> Share

    Int J Cancer

  8. HUSBY A, Wohlfahrt J, Melbye M
    Pregnancy duration and ovarian cancer risk: a 50-year nationwide cohort study.
    Int J Cancer. 2022 Jun 24. doi: 10.1002/ijc.34192.
    >> Share

    J Clin Oncol

  9. BETANCOURT NJ, Qian MF, Pickford JR, Bailey-Healy I, et al
    Gorlin Syndrome: Assessing Genotype-Phenotype Correlations and Analysis of Early Clinical Characteristics as Risk Factors for Disease Severity.
    J Clin Oncol. 2022;40:2119-2127.
    >> Share

    Lancet Oncol

    Rucaparib for recurrent ovarian cancer with BRCA1 and BRCA2 mutations - Authors' reply.
    Lancet Oncol. 2022;23:e315.
    >> Share

  11. GANGULY S, Gogia A
    Rucaparib for recurrent ovarian cancer with BRCA1 and BRCA2 mutations.
    Lancet Oncol. 2022;23:e314.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016